Pacific Biosciences of California, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+41.8% +$32M
$-44M
Free Cash Flow↑+46.8% +$756K
$-861K
Investing Cash Flow↓-55.3% -$32M
$26M
Financing Cash Flow
$0
Capex↓-46.8% -$756K
$861K
Acquisitions
$0
Stock-Based Comp↓-40.2% -$6M
$10M
Debt Issued
—
D&A↓-3.7% -$106K
$3M
SBC Allocated Expense↓-40.2% -$6M
$10M